Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

[A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for pediatric Crohn's disease].

Navas-López VM, Pujol Muncunill G, Llerena E, Navalón Rubio M, Gil-Ortega D, Varea-Calderón V, Sierra Salinas C, Martin-de-Carpi J.

An Pediatr (Barc). 2017 Apr 20. pii: S1695-4033(17)30052-8. doi: 10.1016/j.anpedi.2017.01.013. [Epub ahead of print] Spanish.

2.

[Comparison of the effectiveness and safety of polyethylene glycol with and without electrolytes in the treatment of chronic constipation].

Llerena E, Varea Calderón V, Pujol Muncunill G, Hernandez Hernandez K, Sosa Giraldo FJ, Suarez Fuentes T, Martín de Carpi J.

An Pediatr (Barc). 2016 Jul;85(1):34-40. doi: 10.1016/j.anpedi.2015.08.009. Epub 2015 Oct 23. Spanish.

3.

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O'Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M, Gatzemeier U; FLEX Study Team.

Lancet. 2009 May 2;373(9674):1525-31. doi: 10.1016/S0140-6736(09)60569-9.

PMID:
19410716
4.

Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patients.

Romaguera JE, Rodríguez Díaz-Pavon J, Carías L, Hagemeister FB, McLaughlin P, Rodríguez MA, Sarris AH, Younes A, Preti A, Bachier C, Llerena E, Cabanillas F.

Leuk Lymphoma. 1998 Jan;28(3-4):295-306.

PMID:
9517501
5.

Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.

Verschraegen CF, Levy T, Kudelka AP, Llerena E, Ende K, Freedman RS, Edwards CL, Hord M, Steger M, Kaplan AL, Kieback D, Fishman A, Kavanagh JJ.

J Clin Oncol. 1997 Feb;15(2):625-31.

PMID:
9053486
6.

Remission of a chemotherapy resistant tumor of low malignant potential with tamoxifen.

Llerena E, Kudelka AP, Tornos C, Cedillo GF, Lopez A, Edwards CL, Litam JP, Kavanagh JJ.

Eur J Gynaecol Oncol. 1997;18(1):23-5.

PMID:
9061316
7.

[Synthesis of 15-fluorodeoxyprostaglandins A2 and E2 from Plaxaura homomalla prostaglandin A2].

Bezuglov VV, Serkov IV, Gafurov RG, Llerena EM, Pashinnik VE.

Dokl Akad Nauk SSSR. 1984;279(2):378-80. Russian. No abstract available.

PMID:
6151887

Supplemental Content

Loading ...
Support Center